Yousif Capital Management LLC Sells 166 Shares of Humana Inc. $HUM

Yousif Capital Management LLC lowered its stake in shares of Humana Inc. (NYSE:HUM) by 0.8% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 21,598 shares of the insurance provider’s stock after selling 166 shares during the quarter. Yousif Capital Management LLC’s holdings in Humana were worth $5,280,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Cary Street Partners Investment Advisory LLC grew its stake in Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares during the period. Applied Finance Capital Management LLC grew its stake in Humana by 1.7% in the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock valued at $779,000 after purchasing an additional 48 shares during the period. Blue Trust Inc. grew its stake in Humana by 3.6% in the 2nd quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after purchasing an additional 48 shares during the period. Achmea Investment Management B.V. grew its stake in Humana by 0.5% in the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock valued at $2,746,000 after purchasing an additional 49 shares during the period. Finally, Beech Hill Advisors Inc. grew its stake in Humana by 6.1% in the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock valued at $229,000 after purchasing an additional 50 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on HUM shares. Mizuho upped their price objective on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Wall Street Zen downgraded Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Barclays cut their price target on Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research note on Friday, October 3rd. Morgan Stanley cut their price target on Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research note on Thursday, July 31st. Finally, Bank of America increased their price target on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Eight investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $297.58.

Humana Stock Performance

Shares of HUM opened at $261.19 on Wednesday. The stock’s 50-day simple moving average is $280.05 and its 200 day simple moving average is $258.11. The stock has a market capitalization of $31.41 billion, a price-to-earnings ratio of 20.05, a price-to-earnings-growth ratio of 1.59 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the company posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. Humana’s dividend payout ratio is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.